- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Caravan Health’s Tim Gronniger on Boosting ACO Participation
On this episode of Managed Care Cast, we speak with Tim Gronniger, the CEO of Caravan Health, about what to look for as accountable care organizations (ACOs) and policy makers try to encourage more providers to join value-based care arrangements.
The “muscles” that were created in value-based care programs in the years before the pandemic have been helpful to accountable care organizations (ACOs) in dealing with the turmoil in health care delivery, according to our guest on this week’s Managed Care Cast.
Tim Gronniger, MPP, MHSA, the CEO of Caravan Health, discusses what may come next (or ideally might come next) as ACOs move forward as the United States adjusts to an endemic phase of COVID-19. We discuss financing and policy and what is needed to achieve CMS’ goal of furthering the shift to ACOs by 2030.
Gronniger, former chief of staff and director of Delivery System Reform at CMS in the Obama administration, also discusses the company’s recent acquisition by Signify Health.
Listen above or through one of these podcast services:
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
AA Unlikely to Cause Anxiety, Depression but May Be Affected by Mental Illness
May 7th 2024A Mendelian randomization study using genetic analysis found that alopecia areata (AA) increases the risk of anxiety and depression, but not the other way around, providing unique evidence for a causal link while adding to existing evidence.
Read More
